Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

GYRE THERAPEUTICS, INC. (GYRE) Institutional Ownership & Insider Trading

60 institutions reported holding GYRE THERAPEUTICS, INC. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 18 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

GYREGYRE THERAPEUTICS, INC.Follow GYRE — free
Drug Manufacturers - General · Healthcare
—
Price chart with a free account
Market cap
652.3M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
18 Nov, in 25 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

60 institutions held 7.8% of the shares. Across filers that reported both quarters, shares held changed +154.3%.

Increased+31New+11Decreased-9Closed-5

Largest moves, shares (millions)

HSG Holding+3.8MOctagon Capital Advisors+1.0MBlackRock+0.2MVanguard Capital Management-0.1MBrevan Howard Capital…-0.0MSBI Securities-0.0M

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters
+0.3Sep 24+0.1Dec 24+0.8Mar 25+0.8Jun 25-0.3Sep 25+0.2Dec 25+0.1Mar 26+5.3Jun 26
QuarterHoldersShares held, MChangeIncreasedNewDecreasedClosed
Jun 26609+154.3%311195
Mar 26563+2.9%1710112
Dec 25443+7.9%21294
Sep 25483-9.3%118168
Jun 25473+30.9%25986
Mar 25453+46.0%158143
Dec 24402+4.5%134110
Sep 24362+43.1%14844

GYRE THERAPEUTICS, INC. — questions

Who owns GYRE THERAPEUTICS, INC. stock?
60 institutions reported GYRE THERAPEUTICS, INC. shares in 13F filings for the quarter ended 2026-06-30. The largest: HSG Holding Ltd (3.4%), BlackRock, Inc. (0.9%), Octagon Capital Advisors LP (0.9%).
Are GYRE THERAPEUTICS, INC. insiders buying or selling?
18 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from GYRE THERAPEUTICS, INC.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.